c-fos gene is expressed constitutively in a number of tissues as well as in certain tumor cells and is inducible, in general rapidly and transiently, in virtually all other cell types by a variety of stimuli. Its protein product, c-Fos, is a short-lived transcription factor that heterodimerizes with various protein partners within the AP-1 transcription complex via leucine zipper/leucine zipper interactions for binding to specific DNA sequences. It is mostly, if not exclusively, degraded by the proteasome. To localize the determinant(s) responsible for its instability, we have conducted a genetic analysis in which the half-lives of cFos mutants and chimeras made with the stable EGFP reporter protein were compared under two experimental conditions taken as example of continous and inducible expression. Those were constitutive expression in asynchronously growing Balb/C 3T3 mouse embryo fibroblasts and transient induction in the same cells undergoing the G0/G1 phase transition upon stimulation by serum. Our work shows that c-Fos is degraded faster in synchronousthan in asynchronous cells. This difference in turnover is primarily accounted for by several mechanisms. First, in asynchronous cells, a unique C-terminal destabilizer is active whereas, in serum-stimulated cells two destabilizers located at both extremities of the protein are functional. Second, heterodimerization and/or binding to DNA accelerates protein degradation only during the G0/G1 phase transition. Adding another level of complexity to turnover control, phosphorylation at serines 362 and 374, which are c-Fos phosphorylation sites largely modified during the G0/G1 phase transition, stabilizes c-Fos much more efficiently in asynchronous than in serum-stimulated cells. In both cases, the reduced degradation rate is due to inhibition of the activity of the C-terminal destabilizer. However, in serum-stimulated cells, this effect is partially masked by the activation of the N-terminal destabilizer and basic domain/leucine zipper-dependent mechanisms. Taken together, our data show that multiple degradation mechanisms, differing according to the conditions of expression, may operate on c-Fos to ensure a proper level and/or timing of expression. Moreover, they also indicate that the half-life of c-Fos during the G0/G1 phase transition is determined by a delicate balance between opposing stabilizing and destabilizing mechanisms operating at the same time.
c-fos gene is expressed constitutively in a number of tissues as well as in certain tumor cells and is inducible, in general rapidly and transiently, in virtually all other cell types by a variety of stimuli. Its protein product, c-Fos, is a short-lived transcription factor that heterodimerizes with various protein partners within the AP-1 transcription complex via leucine zipper/leucine zipper interactions for binding to specific DNA sequences. It is mostly, if not exclusively, degraded by the proteasome. To localize the determinant(s) responsible for its instability, we have conducted a genetic analysis in which the half-lives of cFos mutants and chimeras made with the stable EGFP reporter protein were compared under two experimental conditions taken as example of continous and inducible expression. Those were constitutive expression in asynchronously growing Balb/C 3T3 mouse embryo fibroblasts and transient induction in the same cells undergoing the G0/G1 phase transition upon stimulation by serum. Our work shows that c-Fos is degraded faster in synchronousthan in asynchronous cells. This difference in turnover is primarily accounted for by several mechanisms. First, in asynchronous cells, a unique C-terminal destabilizer is active whereas, in serum-stimulated cells two destabilizers located at both extremities of the protein are functional. Second, heterodimerization and/or binding to DNA accelerates protein degradation only during the G0/G1 phase transition. Adding another level of complexity to turnover control, phosphorylation at serines 362 and 374, which are c-Fos phosphorylation sites largely modified during the G0/G1 phase transition, stabilizes c-Fos much more efficiently in asynchronous than in serum-stimulated cells. In both cases, the reduced degradation rate is due to inhibition of the activity of the C-terminal destabilizer. However, in serum-stimulated cells, this effect is partially masked by the activation of the N-terminal destabilizer and basic domain/leucine zipper-dependent mechanisms. Taken together, our data show that multiple degradation mechanisms, differing according to the conditions of expression, may operate on c-Fos to ensure a proper level and/or timing of expression. Moreover, they also indicate Introduction Tight regulation of both the level and the timing of proto-oncogene expression is necessary to avoid cell transformation and tumorigenesis linked to overexpression. This, most often, involves a complex network of transcriptional and post-transcriptional mechanisms exquisitely controlled by intracellular signalling cascades. Moreover, many proto-oncoproteins are shortlived and this feature plays a key role in the rapid adjustment of their abundance in response to a variety of environmental cues. It is widely assumed that destruction of unstable proteins mostly occurs via the ubiquitin/proteasome pathway (Glickman and Ciechanover, 2002; Pickart, 2001) . The broad outlines of protein degradation by this system are now well established. In a first step, substrates undergo covalent marking by ubiquitin chains, which often occurs in response to permissive intracellular signalling events. Then, ubiquitinylated proteins are recognized and hydrolyzed by the proteasome, which is the main proteolytic machinery of the cell (DeMartino and Slaughter, 1999; Kisselev and Goldberg, 2001; Coux, 2002; Glickman and Ciechanover, 2002 ). The precise mechanisms involved in the destruction of specific proteins are, however, most often ill-defined, particularly with regard to the structural determinants permitting substrate selection for destruction. Thus, identification and structural analysis of protein destabilizers, as well as determining whether those are unique or multiple and when they are active, constitute a major goal for a better understanding of the intimate molecular mechanisms of protein breakdown and the design of inhibitors/stimulators of key cell regulator degradation with the aim of pharmacological intervention in a variety of diseases.
c-fos gene defines a multigene family encoding several structurally and functionally related transcription factors (c-Fos, FosB, Fra-1 and Fra-2) contributing to the formation of the AP-1 transcription complex (Chinenov and Kerppola, 2001) . AP-1 is a regulator of major physiological processes such as cell proliferation, differentiation, organogenesis, memory formation, apoptosis, response to stress, etc. (Angel et al., 2001; Chinenov and Kerppola, 2001; Jochum et al., 2001; Macian et al., 2001; Shaulian and Karin, 2001; van Dam and Castellazzi, 2001) . It is also a necessary effector in a variety of pathological situations including tumorigenesis (Angel et al., 2001; Jochum et al., 2001; Shaulian and Karin, 2001; van Dam and Castellazzi, 2001 ). Within AP-1, c-Fos heterodimerizes via leucine zipper (LZ)/leucine zipper interactions with various partners (Chinenov and Kerppola, 2001) , the best known being the Jun family members, and binds to specific DNA motifs (AP-1/TRE and CRE) via a basic domain (DBD) N-terminally adjacent to the LZ (Piechaczyk and Blanchard, 1994; Chinenov and Kerppola, 2001 ). c-fos gene is expressed constitutively in a variety of embryonic and adult tissues (see Curran, 1988; Piechaczyk and Blanchard, 1994; Herdegen and Waetzig, 2001) as well as in a number of tumor cells that, nonexhaustively, include certain osteosarcomas (Gamberi et al., 1998) , HTLV-I-infected T cells (Fujii et al., 1991) , smouldering adult T leukemia cells (Iwahashi et al., 1994) , B-cell lymphomas (Kanaitsuka et al., 1987 (Kanaitsuka et al., , 1988 , Philadelphia chromosome positive chronic myelogenous leukemia (Eibl et al., 1995) , glioma cells (Rubio et al., 1996; Kim et al., 2000) , bovine leukemia virus (BLV)-infected cells (Tajima and Aida, 2002) , theileria-transformed bovine leucocytes (Chaussepied et al., 1998) . In most other cell types, where its expression is low or undetectable, c-fos gene is induced by a wide array of stimuli to permit cell to integrate changes in the extracellular environment (see Curran, 1988; Piechaczyk and Blanchard, 1994; Herdegen and Waetzig, 2001) . Such an induction usually occurs rapidly and transiently within the few hour range (Piechaczyk and Blanchard, 1994) . Finally, unproper expression of c-fos gene is causative of various phenotypic effects. On the one hand, c-fos inactivation results in induction of osteopetrosis in knockout mice (Johnson et al., 1992; Wang et al., 1992) , altered sensitivity to apoptosis in fibroblasts (Schreiber et al., 1995) and retinal cells (Hafezi et al., 1997) , and increased excitability and cell death in neurons (Zhang et al., 2002) . On the other hand, ectopic expression leads to aberrant bone development and tumors in transgenic mice and is sufficient for the transformation of various cell types in vitro (Jochum et al., 2001) . Noteworthy, cfos is rapidly and transiently expressed upon stimulation by serum of quiescent cells and relatively short extension of its physiological windows of expression is sufficient for fibroblasts to manifest various properties of cell transformation (Miao and Curran, 1994) . This underlines the necessity for c-fos gene to be subjected to efficient shut-off mechanisms.
c-Fos is an unstable protein. The involvement of the proteasome in its degradation in vivo is now well established both when the protein is constitutively expressed in asynchronously growing cells (Acquaviva et al., 2001b) and when it is rapidly and transiently induced upon stimulation by serum in quiescent cells (Salvat et al., 1998; Acquaviva et al., 2001a) . However, the need of direct ubiquitinylation for c-Fos degradation has not yet been unambigously established (see discussion for more details). Furthermore, little is known about the nature and the number of the structural determinants responsible for c-Fos instability. The protein contains three PEST motifs (PEST1, PEST2 and PEST3), which are regions rich in proline, glutamic acid, aspartic acid, serine and threonine that have been proposed to constitute general protein destabilizers on the basis of a computational comparison of stable and unstable proteins (Rogers et al., 1986; Rechsteiner and Rogers, 1996) . Particularly, PEST3, which comprises the most C-terminal 20 amino acids (out of 380) of the protein, is commonly thought to constitute the unique c-Fos destabilizer because its deletion entails dramatic c-Fos stabilization in asynchronously growing NIH 3T3 mouse embryo fibroblasts and human HeLa cells Tsurumi et al., 1995) . Though these experiments clearly showed that the Cterminus of c-Fos is essential for rapid turnover in asynchronous cells, they gave no indication on whether PEST3, or a subdomain of it, is sufficient to confer instability to the whole molecule and they did not exclude that the actual destabilizer extended outside of PEST3 or was a composite structure involving other domains of c-Fos. Recently, we have shown that PEST3 deletion leads to only a modest stabilization (twofold factor) in Balb/C 3T3 mouse fibroblasts progressing from G0 to G1 and excluded any role for PEST1 and PEST2 under the same condition of expression (Acquaviva et al., 2001a) . Taken together, the above-mentioned experiments Tsurumi et al., 1995; Acquaviva et al., 2001a) thus suggested that the modes of c-Fos destruction might not, or not exactly, be the same depending on the conditions of c-Fos expression. To test this hypothesis, and gain further insight in to the mechanisms whereby c-Fos is broken down, we have conducted a genetic analysis aiming at localizing the c-Fos destabilizers. In this study, the stability of deletion mutants and chimeras made with the stable EGFP reporter protein were compared in a unique cellular context (Balb/C 3T3 mouse embryo fibroblast) both during asynchronous growth, as a model of constitutive expression, and during the G0/G1 phase transition, as a model of timely regulated expression. We report here that, in asynchronous cells, c-Fos degradation is governed by a unique C-terminal element of the protein bigger than PEST3 whereas, in serum-synchronized fibroblasts, an N-terminal determinant acts together with the C-terminal domain and the DBD/LZ region for a faster degradation of c-Fos. Moreover, in keeping with the observation by others (Chen et al., 1996; Okazaki and Sagata, 1995) , we observed that phosphorylation at serines 362 and 374 stabilizes c-Fos and show that this occurs via limitation of the destabilizing activity of the C-terminal region both in synchronous and asynchronous cells. This stabilizing effect is, however, partially masked by the activation of the N-terminal destabilizer during the G0/G1 phase transition, which raises the possibility that phosphorylation at serines 362 and 374 might also have functions other than the control of c-Fos half-life. In conclusion, our work provides support to the idea that multiple structural determinants may be differentially used for the degradation of proteins depending on the conditions of expression. They also indicate that both destabilizing and stabilizing mechanisms can operate at the same time within the same protein to determine its half-life.
Results
Different structural determinants control c-Fos degradation in asynchronous and serum-stimulated Balb/C 3T3 fibroblasts All experiments were conducted using Balb/C 3T3 mouse embryo fibroblasts either growing asynchronously or undergoing a G0/G1 phase transition upon stimulation of serum-starved, quiescent cells by fresh serum. Under the latter conditions, c-Fos accumulation peaks 1-2 h after stimulation and returns to basal levels within 5-7 h (Acquaviva et al., 2001a; Bravo, 1991, 1992; Lallemand et al., 1997; Shaulian and Karin, 2001 ). For measuring wild-type and mutant c-Fos protein half-lives in asynchronously growing cells, cells were transiently transfected with constitutive cytomegalovirus (CMV) promoter-based expression plasmids ( Figure 1a ) and pulse-chase experiments were conducted 36 h later. In the case of the G0/G1 phase transition, pulse-chase experiments were conducted during the peak of c-Fos expression using serumstimulated fibroblasts that were previously stably transfected with expression plasmids faithfully reproducing c-fos gene expression at the RNA level because of the presence of a minimal serum-regulatable promoter (pSRE) and of the c-fos mRNA 3 0 UTR carrying the (Acquaviva et al., 2001a) owing to a minimal c-Fos promoter region containing the serum-responsive element (pSRE) and the mouse cfos mRNA 3 0 -UTR, which carries the main mRNA destabilizer, were used. In this construct, the 5 0 -UTR is also that of the mouse c-fos gene and proteins were N-terminally tagged with a T7-phage epitope that both does not alter the protein half-life (Acquaviva et al., 2001a) (Figure 1a) . Importantly, (i) stabilization by the proteasome inhibitor MG132 of all instable c-Fos-derived proteins was analysed to rule out that mutations may be responsible for acquisition of sensitivity to another proteolytic system(s) not operating physiologically on c-Fos as it has been reported in the case of mutated Fos proteins expressed by two osteosarcomatogenic viruses (Acquaviva et al., 2001b) and (ii) the intracellular localization of all mutants was monitored to exclude that possible modifications in the degradation rate was simply because of gross intracellular redistribution preventing access to the physiological c-Fos degradation machinery.
In a first step of our investigations, we measured the degradation rate of wild-type c-Fos in asynchronous and serum-stimulated Balb/C 3T3 fibroblasts. Our data showed that the protein is degraded more actively (approximately three-fold difference) during the G0/G1 transition (half-life of 4774 min) than in asynchronously growing cells (half-life of 14376 min) ( Figure 1b) . Next, the behavior of a c-Fos mutant deleted of PEST3 (c-Fos/1-359) was investigated. It was stabilized only twofold in synchronized cells and dramatically in asynchronous ones with a nonmeasurable decay over an 8 h chase (Figure 1b ; also see steady-state level analysis below). This result ruled out that the differential behavior of c-Fos/1-359, previously described in asynchronous NIH 3T3 cells (Okazaki and and serum-synchronized Balb/C 3T3 cells (Acquaviva et al., 2001b) , was because of a difference in cell type and/or culture conditions but, rather, supports the idea that c-Fos is recognized for degradation following, at least partially, different modes under the two conditions of expression studied.
We then measured the half-lives of a DBD mutant (cFosVV mutant) (Ransone et al., 1990) unable to bind to DNA and of an LZ mutant (c-FosVAV mutant) (Schuermann et al., 1989) unable to heterodimerize and consequently to bind to DNA (Figure 1b) . In asynchronously growing cells, both c-FosVV and cFosVAV showed half-lives comparable to that of c-Fos. In contrast, both of them were stabilized approximately twofold during the G0/G1 transition ( Figure 1b) . Thus, an ability to bind DNA and/or to dimerize is not strictly indispensable for c-Fos destruction (see Discussion). It, however, appears to influence the degradation rate in serum-stimulated cells but not in asynchronous ones (also see below).
Then, to roughly map the region(s) of c-Fos conferring instability, we created mutants deleted of the region upstream (c-Fos/140-380 mutant) or downstream (c-Fos/1-196 mutant) of the DBD/LZ (bZip) domain ( Figure 1b ). In asynchronously growing cells, cFos/140-380 showed a half-life comparable to that of the wild-type protein, whereas c-Fos/1-196 was dramatically stabilized (Figure 1b ). In contrast, in cells undergoing the G0/G1 transition, each protein underwent stabilization, but by a factor of 2 ( Figure 1b) .
Importantly, all mutants analysed here were stabilized in the presence of MG132, which is consistent with the involvement of the proteasome in their destruction, except c-Fos/1-359 and c-Fos/1-196 that spontaneously accumulated to high levels in exponential cells because of their dramatic stabilization ( Figure 2a ). Finally, all mutants localized predominantly in the nucleus (Figure 2b ) as full-length c-Fos except c-Fos/140-380, a slight fraction of which was also found in the cytoplasm.
In conclusion, all the structural information required for rapid degradation of c-Fos in asynchronous cells is located in the C-terminal moiety of the protein. In contrast, there are very likely two autonomous destabilizing elements localized in each moiety of the protein that can collaborate to c-Fos destruction during the G0/ G1 transition and whose activity may be modulated by heterodimerization and/or binding to DNA.
The information necessary and sufficient for c-Fos degradation in asynchronously growing cells is located at the C-terminus of the molecule but extends out of PEST3
As a first step to better localize the domain responsible for c-Fos instability in asynchronously growing cells, deletion mutants within the C-terminal moiety of c-Fos ( Figure 3a ) were generated and cloned in the constitutive expression vector presented in Figure 1a . All of them turned out to be exclusively nuclear ( Figure 3b) . Steady-state level directly reflecting stability in transfection assays performed under standardized conditions, Balb/C 3T3 fibroblasts were transiently transfected in parallel with the various plasmids and the relative abundances of the different proteins were compared in immunoblotting experiments. Stabilization in the presence of MG132 for 8 h of mutants retaining all, or part of, instability was also assessed. The data presented in Figure 3c show that c-FosD210-244 and c-FosD250-308, as c-Fos, accumulated at low levels in the absence of MG132 and were dramatically stabilized in the presence of the drug. In contrast, c-FosD309-359 behaved like c-Fos/1-359 since it accumulated to a high level and its abundance did not increase further in the presence of MG132. This suggests that (i) neither PEST2, nor the region including amino acids 250-308, is necessary for rapid c-Fos degradation and (ii) that PEST3, or part of it, as well as upstream elements located between amino acids 309-359 are necessary for instability.
Next, we wanted to establish which domain of c-Fos is sufficient to destabilize a stable protein in asynchronously growing cells. As a reporter protein, we selected EGFP because C-terminal fusion of the C-terminal domain of ornithine decarboxylase protein to it already showed that it is a destabilizable protein (Li et al., 1998) . Moreover, its intrinsic fluorescence allows direct monitoring of intracellular localization of chimeric proteins and, because of its small size, it diffuses efficiently between the nucleus and the cytoplasm. The latter property is important because (i) chimeras made with short fragments of c-Fos would presumably not contain sufficient information to allow intracellular distribution and/or motions comparable to those of full-length c-Fos c-Fos degradation P. Ferrara et al and (ii) the cell compartment where c-Fos is degraded is not known and one cannot exclude that nuclear c-Fos has to return to the cytoplasm for destruction as it has been reported for a number of proteins. In preliminary experiments, we verified that C-terminal grafting of the whole c-Fos (EGFP/c-Fos protein; Figure 4a ) could destabilize EGFP. This was achieved, first, in a transient transfection accumulation assay in which the abundance of EGFP/c-Fos was dramatically lower than that of EGFP ( Figure 4b ) and, then, in pulse-chase experiments where EGFP/c-Fos showed a half-life of 230750 min whereas no detectable decay was observed for EGFP ( Figure 4c ). Importantly, destabilization was inhibited by MG132, which suggests that EGFP/c-Fos is degraded by the proteasome (Figure 4b ). Since deletion studies (Figure 3 ) suggested that the c-Fos destabilizer might be confined to the most C-terminal 72 amino acids, EGFP chimera with various c-Fos fragments spanning amino acids 309-380 (EGFP/309-380), 333-380 (EGFP/333-380) and 360-380 (EGFP/360-380) were constructed and their half-lives were compared in pulse-chase experiments (Figure 4c ). Whereas no detectable decay was observed for EGFP/ 360-380 over 8 h chases, half-lives of EGFP/309-380 and EGFP/333-380 were estimated to be 257745 and 462 min, respectively. Finally, degradation of EGFP/ 309-380 and EGFP/333-380 was inhibited by MG132 in accumulation assays (Figure 4e ). Moreover, although EGFP/c-Fos showed an intracellular distribution comparable to that of c-Fos, as observed for EGFP alone (Figure 4d ), the other chimeras had a diffuse distribution within both the nucleus and the cytoplasm. This indicated that none of the analysed proteins was trapped in a specific cell compartment or subcompartment. Thus, PEST3 alone is not sufficient to explain c-Fos instability in asynchronous Balb/C 3T3 fibroblasts. Rather, a structural determinant(s) located within the last 48 amino acids of the protein, whose effect is enhanced by elements located between amino acids 309-333, contains sufficient information for proteasomal degradation of c-Fos. the last 20 amino acids in the rapid degradation of c-Fos during the G0/G1 phase transition than in asynchronous cells. Pulse-chase experiments also pointed to a role for the N-terminal 49 amino acids since a mutant deleted of this region (c-Fos50-380 mutant) was also partially stabilized (Figure 5a ). To localize more precisely the N-and C-terminal destabilizing elements operating in synchronized cells, EGFP chimeras with various portions of c-Fos C-and N-moieties were analysed. PEST3 was not sufficient to destabilize EGFP. On the contrary, the last 48 amino acids were (Figure 5b ). Noteworthy, a fragment corresponding to the C-terminal 72 amino acids was less efficient than the C-terminal 48 amino acids (Figure 5b ), which differs from the observation in asynchronous cells. The Nterminal 49 amino acids could destabilize EGFP (1-49/ EGFP construct; Figure 5c ). However, stronger effects were observed with longer N-terminal fragments either spanning amino acids 1-140 (1-140/EGFP) or (1-195/EGFP) that also included the bZip domain and was the most efficient. Finally, c-Fos/50-380 and 1-195/ EGFP showed an intracellular distribution comparable to that of c-Fos whereas 1-140/EGFP, 1-91/EGFP and 1-49/EGFP showed a distribution comparable to that of EGFP, ruling out the possibility of retention within an aberrant cell compartment or subcompartment. Moreover, all unstable proteins were stabilized by MG132.
Thus, these data point to the existence of G0/G1 phase transition destabilizing elements residing in each moiety of c-Fos that can operate independent of each other. A C-terminal destabilizer is contained within the last 48 amino acids of the protein and its effect does not seem to be strengthened by the 34 amino acids lying upstream of it. Another destabilizing element is located within the N-terminal 49 amino acids of c-Fos. However, longer N-terminal fragments of c-Fos are more efficient at destabilizing EGFP.
The destabilizing activity of the C-terminus of c-Fos is inhibited by phosphorylation on serines 364 and 372 during both asynchronous growth and the G0/G1 phase transition Phosphorylation on Ser362 and Ser374 by MAP kinases has already been reported to stabilize c-Fos in NIH 3T3 fibroblasts Chen et al., 1996;  see Discussion for more details). We, thus, investigated whether phosphorylation on these two residues had the same effect in asynchronous and serum-stimulated Balb/ C 3T3 cells by measuring the half-life of a c-Fos mutant (c-Fos,S362D,S374D) in which both serines were converted in aspartic acids to mimic phosphorylations. Pulse-chase experiments showed a partial stabilization (twofold factor) of c-Fos,S362D,S374D during the G0/ G1 transition and no detectable decay over an 8 h chase during asynchronous growth (Figure 6a ). In the latter case, our data are consistent with the fivefold stabilization observed for a comparable mutant in asynchronous NIH 3T3 cells . Thus, phosphorylation of serines 362 and 374 induces a higher stabilization in asynchronous cells than in serum-stimulated ones. Then, we investigated whether phosphorylation-induced stabilization involved only Cterminal determinants or other upstream elements as well. To this aim, we compared the effect of the c-Fos 309-380 region in its wild-type configuration (EGFP/ 309-380) or with serines 362 and 374 mutated into aspartic acids (EGFP/309-380,S362D,S374D) on EGFP turnover. In serum-stimulated cells, EGFP/309-380,S362D,S374D was stabilized 2.5-fold whereas no detectable decay was seen over an 8 h chase in asynchronous cells (Figure 6a) . Importantly, (i) the intracellular distribution of c-FosS362D,S374D was comparable to that of the wild-type c-Fos and that of EGFP/309-380S362D,S374D was comparable to those of EGFP/309-380 and EGFP ( Figure 6b ) and (ii) cFos,S362D,S374D and EGFP/309-380,S362D,S374D were stabilized in the presence of MG132 during the G0/G1 phase transition. In conclusion, a similar behavior of EGFP/309-380,S362D,S374D and c-Fos, S362D,S374D indicate that phosphorylation of serine 362 and 374 inhibits the destabilizing activity of c-Fos C-terminus under the two studied conditions, though the effect was stronger in asynchronous cells, and does not appear to require determinants other than those contained within the last 72 amino acids of the protein.
Serines 362 and 374 are targets of Erk kinases (Okazaki and Chen et al., 1996) . Whereas they are largely phosphorylated during the G0/G1 phase transition (Chen et al., 1993 (Chen et al., , 1996 , they are poorly modified in asynchronous cells in relation with the difference in MAP kinase activity. However, quantitative phosphorylation can be obtained upon ectopic expression of the Mos oncogene in exponentially growing cells . We thus took advantage of this situation to delineate the minimal domain required for Erk-induced phosphorylation/ stabilization of c-Fos. To this aim, steady-state levels of EGFP/c-Fos, EGFP/195-380, EGFP/309-380, EGFP/333-380 proteins were compared in transient transfection assays conducted in the presence or in the absence of a c-Mos expression vector. All proteins (Figure 6c) . Thus, the C-terminal 48 amino acids of c-Fos are not sufficient for Erk-mediated stabilization whereas the last 72 are.
Discussion
Using a variety of deletion mutants and chimeras made with the EGFP reporter protein, we have shown that degradation of c-Fos is dependent on a unique Cterminal determinant in Balb/C 3T3 cells growing asynchronously and on additional elements that include the N-terminal region protein and the bZip domain in cells undergoing the G0/G1 phase transition. This provides support to the emerging notion that multiple degradation mechanisms may account for the degradation of the same protein depending on the conditions of expression. For example, different recognition elements for the SCF cdc4 ubiquitin ligase target the Cdc6 DNA replication initiation factor for proteolysis in S and M phases (Perkins et al., 2001 ), sequential proteolytic pathways are responsible for p27 kip cyclin-dependent kinase inhibitor degradation in G1 and S phases (Malek et al., 2001) , basal turnover and TNF-a-induced degradation of the Ikba transcription factor inhibitor are dependent on different structural motifs (Krappmann et al., 1996) and hypoxia-inducible HIF-a transcription factor destruction is dependent upon two destruction domains used under different physiological conditions (Masson et al., 2001) .
Not only the structural determinants used under the two conditions studied here differ, but also the kinetics of destruction with c-Fos degraded three-times faster in G0/G1 cells than in asynchronous ones. Interestingly also, the other members of the c-Fos family show halflives that differ according to their conditions of expression. Thus, (i) the stability of Fra-1 and Fra-2 is dependent upon the continuous presence of serum during cell growth in vitro, but not during the G0/G1 transition, in relation with the degree of phosphorylation of both proteins (Gruda et al., 1994) and (ii) FosB and its truncated splice variant form, DFosB, show very similar half-lives during the G0/G1 transition with (Dobrazanski et al., 1991) ; however, upon induction in specific regions of the brain by a variety of chronic perturbations, differentially phosphorylated isoforms of DFosB are turned over dramatically less efficiently than FosB and nonmodified DFosB (Chen et al., 1997) . Taken with the fact that c-Fos half-life can also be modulated by phosphorylation (Okazaki and Sagata, 1995b ; also see below), these observations suggest that fine tuning of the degradation of protein regulators as important as Fos family members by intracellular signalling cascades is most probably essential for control of a variety of physiological processes.
c-Fos degradation in asynchronously growing cells
Analysis of deletion mutants (c-Fos/1-196 and cFosD333-380, which contains PEST1 and PEST1+-PEST2 and which are stable) showed that, contrary to their proposed role (Rogers et al., 1986; Rechsteiner and Rogers, 1996) , neither the PEST1, nor the PEST2 motif are required for rapid c-Fos degradation in asynchronous cells. This situation is reminiscent of the G0/G1 phase transition (Acquaviva et al., 2001a) . The study of other deletion mutants and of EGFP chimeras indicated that c-Fos destruction by the proteasome is dependent upon a unique destabilizing domain that is contained within the last 48 amino acids of the molecule. Further mutagenesis experiments are required to delineate it precisely and to establish whether it includes all, or only part of, PEST3. The C-terminal 72 amino acids are more efficient than the 48 ones at destabilizing EGFP. Determining whether this is due to the presence of an additional instability determinant within the amino acids 309-333 region of c-Fos or to a structural effectlinked better recognition of a unique C-terminal destabilizer located within the last 48 amino acids by the c-Fos degradation machinery also requires further investigation. Finally, coexpression of the Mos kinase and mutation of serines 362 and 374 into aspartic acids both counteract destabilization of EGFP by the last 72 amino acids of c-Fos (this work) as they stabilize full-length c-Fos . This strengthens the idea that the C-terminal region actually carries the physiological destabilizer of c-Fos operating in asynchronous cells. As mentioned in the introduction, c-Fos is expressed constitutively in a number of tissues and tumor cells. It will thus be interesting to determine whether the same unique Cterminal destabilizer is responsible for its destruction in 
Degradation of c-Fos during the G0/G1 phase transition
The control of c-Fos degradation during the G0/G1 phase transition is more complex and brings into play several mechanisms, some of which, surprisingly, are antagonistic (see model in Figure 7) . A first remarkable point is that, in addition to a C-terminal destabilizer, the N-moiety of c-Fos shows a destabilizing activity in G0/ G1 that is not detectable in asynchronous cells. The first 50 amino acids of c-Fos are sufficient to destabilize EGFP but a stronger effect is obtained when using a longer fragment extending down to the DNA-binding domain (1-140/EGFP). It remains to be clarified whether this observation is explained by the action of several independent destabilizing elements or of a unique N-terminal one better presented in a broader peptidic context. Interestingly, the N-and C-terminal destabilizing determinants are not strictly dependent on each other since they can independently confer instability to EGFP. However, we cannot exclude that a certain degree of coordination between them occurs within cFos. An important question relates both to the timing and the mechanisms of activation of the N-terminal region-dependent degradation of c-Fos. Experiments are currently under way to establish whether c-Fos Nterminus is recognized conditionally, possibly after a specific post-translational modification, by a constitutive degradation machinery or a specialized degradation pathway is activated at specific cell cycle stages, the latter two possibilities not being mutually exclusive.
The destabilizing activity of c-Fos C-terminus also deserves comments. As in the case of asynchronous growth, the PEST3 motif is not sufficient to destabilize EGFP whereas the last 48 amino acids are, which is consistent with the idea that the same instability determinant is used both in asynchronous and serumstimulated cells. This hypothesis is supported by the fact that mutations of serines 362 and 374 into aspartic acids entail stabilization of the EGFP/309-380 protein (EGFP/309-380,S362D,S374D construct) under both conditions. However, the last 72 amino acids of c-Fos, when grafted to EGFP, show a destabilizing activity weaker than that of the last 48 ones in serum-stimulated cells and a stronger one in asynchronous cells. This argues for, at least partially, different mechanisms of action of c-Fos C-terminus under the two conditions studied. Using site-directed mutagenesis of the whole cFos protein, we have previously identified a PTL tripeptide motif spanning amino acids 375-377 that shows a 'degradation-accelerating' activity in cells undergoing the G0/G1 transition (Acquaviva et al., 2001b) . It will be important to determine whether this effect is exerted within the context of the C-terminal destabilizer or whether it, indirectly, influences the activity of the N-terminal one.
Phosphorylation of c-Fos on serines 362 and 374 during the G0/G1 transition is intriguing. As already mentioned, c-Fos is poorly phosphorylated on these two residues in asynchronously growing cells , which permits full activity of a unique Cterminal destabilizer. In contrast, c-Fos is largely and coordinately phosphorylated on the same two residues by Erk and Rsk kinases during the G0/G1 phase transition (Chen et al., 1993 (Chen et al., , 1996 . Although the data Figure 7 Model for c-Fos degradation in asynchronously growing and serum-stimulated cells. Neither PEST1 nor PEST2 are necessary for the degradation of c-Fos. In exponentially growing cells, c-Fos degradation is dependent on a unique C-terminal destabilizer (C-dest.) that includes part or all of PEST3 and that extends upstream of PEST3. The activity of C-dest. can be inhibited by phosphorylation of serines 362 and 374 by Mos kinase-induced Erk kinases. In cells undergoing the G0/G1 transition, c-Fos destruction is dependent upon both a C-terminal and an N-terminal (N-dest.) destabilizer. It is, however, not clear whether the C-dest. used in serum-stimulated and in asynchronous cells are exactly the same. The activity of N-dest. is most probably enhanced by binding to DNA by a mechanism that remains to be identified. That of C-dest. is limited by phosphorylation of serines 362 and 374 by seruminduced Erk and Rsk kinases. Since c-Fos lifespan is much shorter in G0/G1 than during asynchronous growth, the reduced activity of C-dest. is, however, largely compensated by that of N-dest. and by binding to DNA c-Fos degradation P. Ferrara et al by Chen et al. (1996) and by us (Acquaviva et al., 2001b) were not totally identical, the work by both laboratories argues for a stabilizing effect of these phosphorylations in serum-stimulated cells. In summary, (i) Chen et al. have reported, on the one hand, comparable degradation kinetics for wild-type c-Fos and for a double aspartic acid mutant mimicking constitutive phosphorylation of serines 362 and 374 and, on the other hand, a faster breakdown for a nonphosphorylatable double alanine mutant at the same positions (Chen et al., 1996) , (ii) we have seen comparable destruction rates for wildtype c-Fos and for the double alanine mutant (Acquaviva et al., 2001b) although, because of the lack of sensitivity of the immunoblotting assay used in this series of experiments, we could not formally rule out that the half-life of the mutant was shorter than that of c-Fos and (iii) we have measured a twofold longer halflife for the double aspartic mutant as compared to c-Fos (this work). The discrepancy between the observations by the two laboratories is most probably accounted for by a much higher phosphorylation level of c-Fos on serines 362 and 374 (which can be assessed by decreased mobility of phosphorylated proteins in SDS-PAGE; data not shown) in the case of Chen et al. because of the particular experimental setting used by these authors. Interestingly, the EGFP/309-380,S362D,S374D chimera is more stable than the EGFP/309-380 protein but still retains some ability to be degraded by the proteasome. This strongly suggests that phosphorylation of serines 362 and 374 exerts its stabilizing effect by reducing (but not abolishing) the C-terminal destabilizer activity. Such an observation is paradoxical at a moment where the protein is the most unstable. It is, however, reasonable to assume that destabilizer inhibition is a side-product of phosphorylations instrumental for other functions of cFos, such as control of transcription activity, during the G0/G1 transition. This observation also stresses the necessity of additional destruction mechanisms, not operating in asynchronous cells, to eliminate efficiently c-Fos during the G0/G1 transition. The analysis of c-FosVV and c-FosVAV mutant suggests that binding to DNA and/or heterodimerization accelerate c-Fos degradation during the G0/G1 transition but not in asynchronous cells. As binding to DNA is dependent upon the ability to dimerize, it is not possible to discriminate between a dimerization-or a DNA-binding effect in the case of the c-FosVAV mutant. However, ectopic expression of a c-Jun mutant (JunDRK; Ransone et al., 1990) , no longer able to bind to an AP-1 DNA motif (both in the form of a homodimer and that of a heterodimer) but showing increased affinity for c-Fos, entailed a threefold stabilization of endogenous c-Fos in serum-synchronized cells (data not shown). This suggests that binding to DNA is the critical point for faster c-Fos degradation in serum-stimulated cells. Our experiments, however, gave no indication on whether accelerated degradation occurs when c-Fos is bound to DNA or after having exerted its role in transcription control. It is also not clear whether the DNA-binding domain constitutes an autonomous destabilizer or whether it facilitates the action of another destabilizer. It is nevertheless interesting to note that the most unstable EGFP chimera involving N-terminal portions of c-Fos is the one which carries the DBD, making likely the possibility that binding to DNA permits a more efficient use of the N-terminal destabilizer. This hypothesis is all the more to be taken into consideration that C-terminal destabilizer activity is reduced in G0/G1. The development of a reliable in vitro degradation assay should help to clarify all these issues.
Another point worth being considered is that the G0/ G1 transition constitutes a particular and transient state with important changes in the composition and the activity of the various AP-1 complexes in the cell. It must thus be taken into account that changes in dimerization partners might affect the way c-Fos is degraded to a certain extent in comparison with the exponential proliferation state, for example, via an 'optimal destabilizer' contributed by portions from both proteins. Supporting this possibility, Papavassiliou et al. (1992) have shown that a phosphorylation-dependent signal on c-Jun can enhance c-Fos degradation in an in vitro degradation assay. The approach used in this work just permitted the follow-up of the whole population of c-Fos-derived molecules expressed in the cells. It would thus be interesting to analyse the degradation of c-Fos within specific dimers. c-Fos-containing tethered AP-1 dimers in which monomers are joined via a flexible polypeptide tether to force specific pairing such as those developed by Bakiri et al. (2002) might be useful to address this issue.
Finally, it is important to underline that c-Fos is rapidly and transiently induced in many cell types by a wide variety of stimuli in a cell cycle-independent manner (Curran, 1988) and that its turnover can be accelerated in various situations such as in WEHI7.2 lymphoma cells undergoing apoptosis (He et al., 1998) or in TPA-treated mouse fibroblasts in the presence of curcumin (Huang et al., 1995) . It would, thus, be interesting to investigate whether degradation of c-Fos in these conditions is dependent on a unique C-terminal destabilizer or also involves multiple destabilizing elements.
Mechanisms of action of c-Fos destabilizing elements
An important question relates to the mechanisms of action of the c-Fos destabilizing elements. The ubiquitin pathway has been proposed to be responsible for c-Fos proteasomal degradation (Stancovski et al., 1995) , although its real involvement is still unclear. c-Fos has thus been reported to be ubiquitinylated in vitro by semipurified ubiquitinylating enzymes (Stancovski et al., 1995; Hermida-Matsumoto et al., 1996) . However, whether these enzymes can actually ubiquitinylate it in vivo has not been investigated and ubiquitinylated forms of c-Fos have never been described in living cells. Moreover, c-Fos is stabilized to some extent in a cell line thermosensitive for the ubiquitin pathway (Stancovski et al., 1995) but not in another (Salvat et al., 1998) . Finally, a direct interaction between c-Fos and the Sug1 subunit of the 19S proteasome regulatory complex has c-Fos degradation P. Ferrara et al been detected both in vitro and in vivo independently of ubiquitinylation (Wang et al., 1996) and recombinant cFos is a very sensitive substrate for purified rat liver proteasome in the absence of ubiquitin (our unpublished data). It must thus be considered that c-Fos destabilizers might not act via ubiquitinylation-dependent mechanisms. It has been proposed that protein degrons and transactivation domains overlap within transcription factors (see Thomas and Tyers, 2000; Tansey, 2001 and references therein). Licensing for transcription would thus also licence transcription factor for destruction in order to protect cells from uncontrolled transcription activity and to allow rapid reprogramming of the transcription apparatus after changes in the cellular status. This model, however, does not fully apply to cFos because ability to transactivate and fast degradation can be experimentally dissociated. For example, mutants deleted of the C-terminal 48 amino acids are still transcriptionally very active in asynchronous cells (Chen et al., 1996 and our unpublished data) and a mutant deleted of the N-terminal 50 amino acids is also transcriptionally competent (data not shown) and significantly stabilized in G0/G1 cells. However, as suggested by stabilization of the c-FosVV mutant in G0/ G1, commitment of c-Fos in transcription is very likely to accelerate its degradation rate, at least in serumstimulated cells. As already mentioned, c-Fos interacts directly with Sug1 (Wang et al., 1996) which (i) in addition to be part of the 26S proteasome (DeMartino and Slaughter, 1999) can act in a proteasome-independent manner in transcription complexes (Ferdous et al., 2001; Gonzalez et al., 2002) and (ii) has been implicated in the destruction of various transcription factors (Gianni et al., 2002; Masuyama and MacDonald, 1998; Su et al., 2000) . Determining whether Sug1, possibly in concert with the N-terminal destabilizer, contributes to faster c-Fos breakdown in G0/G1 by facilitating recognition by the proteasome thus constitutes an attractive possibility. Finally, it is intriguing that the c-Fos destabilizers operating in G0/G1 are located at both extremities of the molecule. Since preferential direction for processing by the proteasome has already been reported for model substrates (Navon and , it is tempting to speculate that cFos is preferentially degraded from its C-terminus in asynchronous cells and from both extremities in G0/G1. This possibility is supported by the finding that both Nand C-terminal grafting of c-Fos destabilize the globular EGFP protein in serum-stimulated cells, whereas only C-terminal grafting can do it in asynchronously growing cells (data not shown).
In conclusion, we report for the first time that c-Fos protein instability depends on multiple determinants, the contribution of which may differ according to the conditions of expression. Surprisingly, we also show that the short half-life of c-Fos during the G0/G1 phase transition is not simply determined by the additive action of several destabilizing elements but by a delicate balance between opposing stabilizing and destabilizing mechanisms operating at the same time (see Figure 7) . It would thus be important to establish whether this also concerns other short-lived proteins whose lifespan is controlled by post-translational modifications.
Materials and methods

Plasmids, mutagenesis and expression vectors
Wild-type and mutant rat c-Fos protein coding sequences were PCR-amplified from a synthetic cDNA (Abate et al., 1990) according to standard protocols using Taq DNA polymerase (Promega, Saint Quentin Fallavier, France). For constitutive expression in asynchronously growing cells, they were cloned downstream of the CMV enhancer/promoter into the pcDNA3 plasmid (InVitrogen, Cergy-Pontoise, France). For expression during the G0/G1 transition, they were cloned in a housemade serum-inducible vector (PM302) (Acquaviva et al., 2001a) , the properties of which are described in the Results section. This plasmid is a modified version of the PFL3F vector (Rech and Fort, 1989) and permits the expression of T7 phage epitope-tagged proteins after cloning of coding sequences into EcoRI and XhoI restriction sites. Modification of c-Fos coding sequences were mostly made using PCRmediated mutagenesis. All constructs were verified by nucleotide sequencing. The list of the various expression plasmids and proteins they encode is presented in Table 1 . The pCDNA3-Ha-Mos expression plasmid in which a human c-mos cDNA is expressed pran the CMV promoter was kindly provided by Dr S Leibovitch (Pran Villejuif, France). Transfections were performed using the calcium phosphate coprecipitation procedure as described in Sambrook et al. (1989) . For protein stability analysis in asynchronously growing cells, 1.5 Â 10 6 Balb/c 3T3 fibroblasts were transiently transfected with 20 mg of pCDNA3-based expression plasmids and, 36 h later, either pulse-chase experiments were conducted or cells were collected for immunoblotting analysis. In the latter case, cells were also cotransfected with 1 mg of CMV promoter-based vectors expressing EGFP (pEGFPC1; Clontech) or the firefly luciferase (CD135; kind gift of Dr I Barlat, Evry, France) as internal standards for analysis of c-Fos mutants or EGFP chimeras, respectively. Firefly activity was assayed using the Reportalight kit from Clontech. EGFP fluorescence was measured by using the SFM25 spectrofluorometer from Kontron Instruments (Watford, UK). Protein stability during the G0/G1 phase transition was investigated using Balb/c 3T3 cell populations stably transfected with PM302-based vectors. For the synchronization experiments, cells were serum-deprived for 36 h to arrest them in G 0 and, then, stimulated by addition of fresh medium containing 20% serum. For inhibition of the proteasome activity, MG132 was added at a final concentration of 5 mm from a 50 mm stock solution in dimethyl-sulfoxide. Cotransfection experiments of c-Fos and Mos were carried using 5 mg of the former vector and 10 of the latter.
Pulse-chases, electrophoresis and immunoblotting experiments
Protein extracts were prepared after cell lysis in RIPA buffer (50 mm Tris-HCl pH 7.5, 150 mm NaCl, 0.02% NaN 3 , 0.1% SDS, 1% NP40, 0.5% sodium deoxycholate, 2 mg/ml leupeptin, 2 mg/ml aprotinin and 1 mm phenyl-methyl-sulfonyl fluoride) as already described (Acquaviva et al., 2001a, b) . Proteins were fractionated through SDS-containing 12% polyacrylamide gels (Sambrook et al., 1989) . For protein half-live measurements, cells (1 Â 10 6 in the case of serumstimulated cells and approximately 4 Â 10 6 for asynchronous ones) were radiolabelled for 1 h in the presence of 150 mCi of a [ 35 S]methionine and cysteine mixture (NEN-Life Science; NEG-772) per ml of culture medium as described elsewhere (Acquaviva et al., 2001b) either 36 h post-transfection, in the case of constitutive c-Fos expression, or 30 min post-serum stimulation in that of transient expression during the G0/G1 phase transition. Chases were performed as follows: cells were rinsed once with PBS (150 mm NaCl, 10 mm Na phosphate pH7), twice with culture medium and, then, incubated in the presence of nonradioactive medium containing 10 mm cold methionine and 10 mm cold cysteine for various periods of time. In the case of asynchronously growing cells, immunoprecipitations were carried out with the highly specific sc52 or H125 antisera (Santa-Cruz Biotechnology), which recognize the N-terminus and a peptide motif located C-terminally to the LZ of c-Fos, respectively. During the G0/G1 phase transition, they were performed with the anti-T7 epitope monoclonal antibody from Novagen. In both cases, immunocomplexes were recovered by centrifugation using bovine serum albuminpreblocked Protein A-agarose (sc2002; Santa-Cruz Biotechnology) and directly resuspended in electrophoresis loading buffer (Salvat et al., 1998; Acquaviva et al., 2001a, b) . Gels were dried and analysed using the 445SI PhosphorImager technology from Molecular Dynamics after 24 h of exposure. For immunoblotting analysis, proteins were electrotransferred on PVDF membranes and immunodetection using the same anti-c-Fos and anti-EGFP antisera as above was performed as described (Salvat et al., 1998; Acquaviva et al., 2001a, b) using the Renaissance chemoluminescence kit from New England Nuclear.
Intracellular protein localization and immunolocalization analysis
Intracellular localization of EGFP-based proteins was directly analysed under a fluorescence microscope. Indirect immunofluorescence assays were carried out essentially as described in Roux et al. (1990) using the sc52 and H125 anti-c-Fos antisera after paraformaldehyde fixation and Triton X-100 permeabilization of cells. Staining of nuclei was performed with a 0.5 mg/ml Hoescht 33342 (Sigma) solution for 2 min at room temperature.
Abbreviations DBD, DNA-binding domain; LZ, leucine zipper; bZIP, basic DNA-binding domain/leucine zipper; EGFP, Enhanced green fluorescent protein.
